Coremine Vitae provides personalized cancer treatment recommendations by analyzing patient-specific data, including biomarkers and clinical guidelines, to inform treatment decisions. This approach empowers patients and their families to understand all relevant treatment options and engage effectively with their healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Cancer patients often lack comprehensive, personalized information about all available treatment options, making it difficult to engage in informed discussions with their healthcare providers. This information gap can lead to uncertainty and limit the patient's ability to actively participate in treatment decisions.
Solution
Coremine Vitae provides cancer patients with personalized treatment insights by analyzing patient-specific data, including biomarkers, clinical guidelines, emerging treatments, and clinical trial options. The platform aggregates and synthesizes this information into an accessible report, empowering patients and their families to understand their treatment landscape and collaborate effectively with their healthcare teams. By offering a comprehensive overview of relevant treatment possibilities, Coremine Vitae aims to instill confidence that all options have been thoroughly evaluated.
Target Audience
Coremine Vitae primarily serves cancer patients and their families seeking comprehensive, personalized information to support informed treatment decisions.
Features
- Analysis of patient-specific data, including biomarkers and medical history
- Identification of relevant national and international clinical guidelines
- Information on emerging cancer treatments and therapies
- Matching of patients to suitable clinical trial opportunities
- Generation of personalized reports summarizing treatment options